Japan Tobacco Releases Latest Ploom Research: May Reduce Harmful Substances in the Body

Japan Tobacco recently announced that a clinical study has shown that when healthy adult smokers in Japan switch to the company's vapor product Ploom TECH, the levels of harmful and potentially harmful constituents (HPHC) in their bodies decrease.

The study was conducted in consultation with Professor Yuji Kumagai, a medical doctor at Kitasato Clinical Research Center.

Researchers randomly assigned 60 healthy adult smokers in Japan into three groups for five days: (a) members switched to Ploom TECH (PT); (b) members continued smoking their own brand of cigarettes (CC); or (c) a quit smoking group (SA).

After the five-day study period, the levels of 15 exposure biomarkers in the PT group were significantly lower compared to the CC group. Moreover, the reduction in exposure biomarkers observed in the PT group was similar to that in the SA group.

In a report published on its website, Japan Tobacco stated that the study results indicate that completely switching from combustible cigarettes to Ploom TECH can significantly reduce exposure and absorption of selected HPHC. While further research is needed, these results strongly support the potential of Ploom TECH to reduce smoking-related health risks.

Japan Tobacco noted that currently, there is no globally agreed standard for assessing the relative health risks associated with the use of different tobacco or other nicotine-containing products, although some countries have established guidelines in this area.